{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:38:29Z","timestamp":1788910709956,"version":"build-2803163510"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/fpc.0b013e328361c39d","type":"journal-article","created":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T00:52:49Z","timestamp":1367455969000},"page":"333-340","source":"Crossref","is-referenced-by-count":26,"title":["ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse"],"prefix":"10.1097","volume":"23","author":[{"given":"Catherine J.","family":"Spellicy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-1-20210213","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"key":"R3-1-20210213","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1520\/JFS2003221","article-title":"Methadone-related deaths in Palm Beach County.","volume":"49","author":"Wolf","year":"2004","journal-title":"J Forensic Sci"},{"key":"R4-1-20210213","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0376-8716(94)01058-S","article-title":"Cocaine use and HIV risk behavior in methadone maintenance patients.","volume":"37","author":"Bux","year":"1995","journal-title":"Drug Alcohol Depend"},{"key":"R5-1-20210213","first-page":"205","article-title":"Factors associated with client-reported HIV infection among clients entering methadone treatment.","volume":"9","author":"MacGowan","year":"1997","journal-title":"AIDS Educ Prev"},{"key":"R6-1-20210213","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0376-8716(94)90092-2","article-title":"HIV infection and cocaine use in methadone maintained and untreated intravenous drug users.","volume":"36","author":"Meandzija","year":"1994","journal-title":"Drug Alcohol Depend"},{"key":"R7-1-20210213","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2105\/AJPH.85.1.83","article-title":"Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use.","volume":"85","author":"Hartel","year":"1995","journal-title":"Am J Public Health"},{"key":"R8-1-20210213","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF02287318","article-title":"The long-term outcomes of drug use by methadone maintenance patients.","volume":"30","author":"Bovasso","year":"2003","journal-title":"J Behav Health Serv Res"},{"key":"R9-1-20210213","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00005053-198803000-00006","article-title":"Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up.","volume":"176","author":"Kosten","year":"1988","journal-title":"J Nerv Ment Dis"},{"key":"R10-1-20210213","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1300\/J069v17n04_07","article-title":"Changes in HIV risk behaviors among cocaine-using methadone patients.","volume":"17","author":"Magura","year":"1998","journal-title":"J Addict Dis"},{"key":"R11-1-20210213","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1081\/JA-120016225","article-title":"Treating cocaine-using methadone patients: predictors of outcomes in a psychosocial clinical trial.","volume":"37","author":"Magura","year":"2002","journal-title":"Subst Use Misuse"},{"key":"R12-1-20210213","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0306-4603(87)90042-6","article-title":"The effect of increased cocaine use on drug treatment.","volume":"12","author":"Black","year":"1987","journal-title":"Addict Behav"},{"key":"R13-1-20210213","first-page":"608","article-title":"Predicting cocaine use among methadone patients: analysis of findings from a national study.","volume":"43","author":"Dunteman","year":"1992","journal-title":"Hosp Community Psychiatry"},{"key":"R14-1-20210213","first-page":"CD002950","article-title":"Antidepressants for cocaine dependence.","volume":"2","author":"Lima","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R15-1-20210213","first-page":"CD002023","article-title":"Carbamazepine for cocaine dependence.","volume":"2","author":"Lima","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-1-20210213","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archpsyc.61.3.264","article-title":"Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial.","volume":"61","author":"Carroll","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"R17-1-20210213","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1360-0443.1998.9357137.x","article-title":"Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram.","volume":"93","author":"Carroll","year":"1998","journal-title":"Addiction"},{"key":"R18-1-20210213","first-page":"116","article-title":"Psychotherapeutic treatment of cocaine abuse: models for its evaluation alone and in combination with pharmacotherapy.","volume":"135","author":"Carroll","year":"1993","journal-title":"NIDA Res Monogr"},{"key":"R19-1-20210213","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0006-3223(99)00310-8","article-title":"Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial.","volume":"47","author":"George","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R20-1-20210213","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts.","volume":"95","author":"Petrakis","year":"2000","journal-title":"Addiction"},{"key":"R21-1-20210213","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/taap.1996.0147","article-title":"Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine.","volume":"139","author":"Vaccari","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"R22-1-20210213","first-page":"435","article-title":"Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence.","volume":"41","author":"Johnson","year":"1989","journal-title":"Pharmacol Rev"},{"key":"R23-1-20210213","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00213-005-0139-8","article-title":".Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice.","volume":"183","author":"Bourdelat-Parks","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R24-1-20210213","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/sj.npp.1301000","article-title":".Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine.","volume":"31","author":"Schank","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"R25-1-20210213","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrg1635","article-title":"The genetics of addictions: uncovering the genes.","volume":"6","author":"Goldman","year":"2005","journal-title":"Nat Rev Genet"},{"key":"R26-1-20210213","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1126\/science.278.5335.45","article-title":"Addiction is a brain disease, and it matters.","volume":"278","author":"Leshner","year":"1997","journal-title":"Science"},{"key":"R27-1-20210213","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1360-0443.2003.00438.x","article-title":"How important is treatment One-year outcomes of treated and untreated alcohol-dependent individuals.","volume":"98","author":"Weisner","year":"2003","journal-title":"Addiction"},{"key":"R28-1-20210213","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.59.6.538","article-title":"A national 5-year follow-up of treatment outcomes for cocaine dependence.","volume":"59","author":"S impson DD, Joe","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"R29-1-20210213","first-page":"91","article-title":"Emerging pharmacological strategies in the fight against cocaine addiction.","volume":"11","author":"Sofuoglu","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"R30-1-20210213","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopsych.2012.07.011","article-title":"Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine beta-hydroxylase.","volume":"73","author":"Kosten","year":"2013","journal-title":"Biol Psychiatry"},{"key":"R31-1-20210213","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/02699050802263019","article-title":".Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study.","volume":"22","author":"McAllister","year":"2008","journal-title":"Brain Inj"},{"key":"R32-1-20210213","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00406-012-0348-1","article-title":".Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol.","volume":"263","author":"Giegling","year":"2013","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R33-1-20210213","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/hmg\/ddm240","article-title":"Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.","volume":"16","author":"Yang","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R34-1-20210213","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1530-0277.2008.00800.x","article-title":"Haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 are associated with comorbid alcohol and drug dependence.","volume":"32","author":"Yang","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"R35-1-20210213","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1022191012698","article-title":"Analysis of the linkage of the Taq1A and Taq1B loci of the dopamine D2 receptor gene with schizophrenia in patients and their siblings.","volume":"33","author":"Golimbet","year":"2003","journal-title":"Neurosci Behav Physiol"},{"key":"R36-1-20210213","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/mp.2008.30","article-title":"Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan.","volume":"14","author":"Glatt","year":"2009","journal-title":"Mol Psychiatry"},{"key":"R37-1-20210213","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.1991.03470130073032","article-title":".The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders.","volume":"266","author":"Comings","year":"1991","journal-title":"JAMA"},{"key":"R38-1-20210213","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.psychres.2011.09.024","article-title":".A DRD2 and ANKK1 haplotype is associated with nicotine dependence.","volume":"196","author":"Voisey","year":"2012","journal-title":"Psychiatry Res"},{"key":"R39-1-20210213","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0741-8329(91)90693-Q","article-title":".Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism.","volume":"8","author":"Blum","year":"1991","journal-title":"Alcohol"},{"key":"R40-1-20210213","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1001\/jama.1990.03440150063027","article-title":".Allelic association of human dopamine D2 receptor gene in alcoholism.","volume":"26","author":"Blum","year":"1990","journal-title":"JAMA"},{"key":"R41-1-20210213","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.addbeh.2006.04.006","article-title":"Heavy nicotine and alcohol use in alcohol dependence is associated with D2 dopamine receptor (DRD2).","volume":"32","author":"Connor","year":"2007","journal-title":"Addict Behav"},{"key":"R42-1-20210213","first-page":"35","article-title":"Polymorphisms of the D2 dopamine receptor gene and alcoholism and other substance use disorders.","volume":"2","author":"Noble","year":"1994","journal-title":"Alcohol Alcohol Suppl"},{"key":"R43-1-20210213","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/archpsyc.1991.01810310066012","article-title":"Allelic association of the D 2 dopamine receptor gene with receptor-binding characteristics in alcoholism.","volume":"48","author":"Noble","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"R44-1-20210213","doi-asserted-by":"crossref","first-page":"20552","DOI":"10.1073\/pnas.0707106104","article-title":".Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"R45-1-20210213","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/npp.2010.208","article-title":"Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.","volume":"36","author":"Moyer","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"R46-1-20210213","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.mp.4000532","article-title":"Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.","volume":"4","author":"Jonsson","year":"1999","journal-title":"Mol Psychiatry"},{"key":"R47-1-20210213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.biopsych.2009.08.012","article-title":".The ANKK1 gene associated with addictions is expressed in astroglial cells and upregulated by apomorphine.","volume":"67","author":"Hoenicka","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R48-1-20210213","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0920-9964(00)00085-2","article-title":"Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients.","volume":"49","author":"Dubertret","year":"2001","journal-title":"Schizophr Res"},{"key":"R49-1-20210213","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0376-8716(93)90113-5","article-title":".Allelic association of the D2 dopamine receptor gene with cocaine dependence.","volume":"33","author":"Noble","year":"1993","journal-title":"Drug Alcohol Depend"},{"key":"R50-1-20210213","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The Fifth Edition of the Addiction Severity Index.","volume":"9","author":"McLellan","year":"1992","journal-title":"J Subst Abuse Treat"},{"key":"R51-1-20210213","first-page":"22","article-title":".The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R52-1-20210213","first-page":"923","article-title":"Manual-guided psychosocial treatment.","volume":"54","author":"Carroll","year":"1997","journal-title":"A new virtual requirement for pharmacotherapy trials Arch Gen Psychiatry"},{"key":"R53-1-20210213","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1601-183X.2012.00839.x","article-title":"Modifying the role of serotonergic 5-HTTLPR and TPH2 variants on disulfiram treatment of cocaine addiction: a preliminary study.","volume":"11","author":"Nielsen","year":"2012","journal-title":"Genes Brain Behav"},{"key":"R55-1-20210213","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00008571-199606000-00004","article-title":".A study of the dopamine D2 receptor gene in pathological gambling.","volume":"6","author":"Comings","year":"1996","journal-title":"Pharmacogenetics"},{"key":"R56-1-20210213","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0006-3223(95)00483-1","article-title":"D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers.","volume":"40","author":"Persico","year":"1996","journal-title":"Biol Psychiatry"},{"key":"R57-1-20210213","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/1096-8628(20001009)96:5<592::AID-AJMG3>3.0.CO;2-Y","article-title":".The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment.","volume":"96","author":"Lawford","year":"2000","journal-title":"Am J Med Genet"},{"key":"R58-1-20210213","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/14622200410001734030","article-title":"The genetic basis for smoking behavior: a systematic review and meta-analysis.","volume":"6","author":"Munafo","year":"2004","journal-title":"Nicotine Tob Res"},{"key":"R59-1-20210213","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1744-9081-3-25","article-title":".Allelic and genotypic associations of DRD2 TaqI A polymorphism with heroin dependence in Spanish subjects: a case control study.","volume":"3","author":"Perez de los Cobos","year":"2007","journal-title":"Behav Brain Funct"},{"key":"R60-1-20210213","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.euroneuro.2005.12.001","article-title":"Association between the dopamine D2 receptor TaqIA A2 allele and low activity COMT allele with obsessive-compulsive disorder in males.","volume":"16","author":"Denys","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"R61-1-20210213","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF03327583","article-title":".D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity.","volume":"12","author":"Nisoli","year":"2007","journal-title":"Eat Weight Disord"},{"key":"R62-1-20210213","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/humu.20039","article-title":"Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11p23.1.","volume":"23","author":"Neville","year":"2004","journal-title":"Hum Mutat"},{"key":"R63-1-20210213","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1073\/pnas.95.13.7731","article-title":"Prominence of the dopamine D2 short isoform in dopaminergic pathways.","volume":"95","author":"Khan","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R64-1-20210213","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nn1737","article-title":".PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys.","volume":"9","author":"Nader","year":"2006","journal-title":"Nat Neurosci"},{"key":"R65-1-20210213","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00008571-199712000-00006","article-title":".D2 dopamine receptor gene (DRD2) Taq1A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.","volume":"7","author":"Thompson","year":"1997","journal-title":"Pharmacogenetics"},{"key":"R66-1-20210213","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1021648128758","article-title":"Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.","volume":"28","author":"Ritchie","year":"2003","journal-title":"Neurochem Res"},{"key":"R67-1-20210213","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.mp.4000350","article-title":"The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.","volume":"3","author":"Pohjalainen","year":"1998","journal-title":"Mol Psychiatry"},{"key":"R68-1-20210213","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/j.1530-0277.2007.00470.x","article-title":".Family-based association analyses of alcohol dependence phenotypes across DRD1 and neighboring gene ANKK1.","volume":"31","author":"Dick","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"R69-1-20210213","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1093\/hmg\/ddl426","article-title":".Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations.","volume":"15","author":"Gelernter","year":"2006","journal-title":"Hum Mol Genet"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0b013e328361c39d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T23:22:06Z","timestamp":1715296926000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201307000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e328361c39d","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}